THE FREQUENCY AND EFFICACY ASSESSMENT OF RADIOIODINE THERAPY FOR DISTANT METASTASES OF THYROID CANCER
2 2025
Изменен: 30.04.2025Путь: Главная / Публикации
THE FREQUENCY AND EFFICACY ASSESSMENT OF RADIOIODINE THERAPY FOR DISTANT METASTASES OF THYROID CANCER
... increasing. In 2023 the incidence rate rose by 13.1% compared to the previous year. Radioactive iodine therapy (I-131) is the primary treatment method for highly differentiated thyroid cancer (HDTC) following surgical tumor removal. However, in some patients distant metastases may develop, worsening the prognosis and necessitating an assessment of the effectiveness of radioiodine therapy in such cases. Objective: To study the incidence of distant metastases and evaluate the effectiveness of radioiodine therapy ...
Изменен: 30.04.2025Путь: Главная / Home / Publications
Результаты поиска 1 - 2 из 2
Начало | Пред. | 1 | След. | Конец
Отсортировано по релевантности | Сортировать по дате